TrialCalcified tissue international2021

Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia.

Raja Padidela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.